BG
KMTS

Bellevue Group’s Kestra Medical Technologies KMTS Stock Holding History

Bellevue Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.3M Sell
115,590
-165
-0.1% -$3.89K 0.05% 77
2025
Q4 		$3.07M Sell
115,755
-12,956
-10% -$334K 0.06% 87
2025
Q3 		$3.06M Sell
128,711
-5,050
-4% -$90.3K 0.06% 86
2025
Q2 		$2.22M Hold
133,761
– – 0.05% 94
2025
Q1 		$3.33M Buy
+133,761
New +$3.07M 0.07% 93

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bellevue Group's KMTS Position: Q1 2026 in Review

Bellevue Group reduced its Kestra Medical Technologies (KMTS) stake by 0.14% in Q1 2026, selling an estimated $3.89K and leaving 115,590 shares worth $2.3M. The position accounts for 0.05% of the portfolio, ranked #77.

Bellevue Group first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.33M in Q1 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Bellevue Group held 115,590 shares of Kestra Medical Technologies worth $2.3M as of Q1 2026.
  • Bellevue Group sold 165 Kestra Medical Technologies shares in Q1 2026, an estimated $3.89K.
  • Kestra Medical Technologies made up 0.05% of Bellevue Group's portfolio in Q1 2026, its #77 holding.
  • Bellevue Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Bellevue Group's Kestra Medical Technologies position peaked at $3.33M in Q1 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.